Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002817 stock hub

SHE/002817 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002817is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002817

In the news

Latest news · SHE/002817

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E37.4

P25 23.5P50 41.3P75 83.2

ROE6.6

P25 -0.9P50 4.1P75 8.8

ROIC6.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002817 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	639
Employees Change	-68%
Employees Change Percent	-9.08
Enterprise value	CNY 2.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002BV5
Last refreshed	2026-05-10
Market cap	CNY 2.5B
Price	CNY 8.22
Price currency	CNY
Rev Per Employee	684,152.46x
Sector	Healthcare
Sic	2834
Symbol	she/002817
Website	https://www.hsjn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.58%
EV Earnings	37.02x
EV/EBIT	40.43x
EV/EBITDA	22.35x
EV/FCF	35.4x
EV/Sales	5.38x
FCF yield	2.7%
P/B ratio	2.51x
P/E ratio	37.44x
P/S ratio	5.62x
PE Ratio10 Y	46.75x
PE Ratio3 Y	36.99x
PE Ratio5 Y	38.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.3%
EBITDA Margin	23.91%
FCF margin	15.19%
Gross margin	30.14%
Gross Profit	CNY 131.7M
Gross Profit Growth	4.72%
Gross Profit Growth Q	-9.02%
Gross Profit Growth3 Y	0.17%
Gross Profit Growth5 Y	4.88%
Net Income	CNY 63.5M
Net Income Growth	20.37%
Net Income Growth Q	-7.83%
Net Income Growth Years	1%
Net Income Growth3 Y	-1.76%
Net Income Growth5 Y	6.19%
Pretax Margin	16.5%
Profit Margin	14.53%
Profit Per Employee	CNY 99,391
Profitable Years	15
ROA	3.28
Roa5y	3.07
ROCE	5.85
ROE	6.62
Roe5y	6.84
ROIC	6.1
Roic5y	8.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.61%
Cagr3y	-0.63%
Cagr5y	4.98%
Div CAGR3	5.77%
Div CAGR5	10.62%
EPS Growth	28.88
EPS Growth Years	1
EPS Growth3 Y	0.12
EPS Growth5 Y	7.05
FCF Growth	-19.07%
FCF Growth3 Y	78.13%
OCF Growth	-19.97%
OCF Growth10 Y	11.97%
OCF Growth3 Y	18.29%
OCF Growth5 Y	5.33%
Revenue Growth	-7.79x
Revenue Growth Q	-19.53x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.4x
Revenue Growth5 Y	4.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.39
Assets	CNY 1.1B
Cash	CNY 108.6M
Current Assets	CNY 376.5M
Current Liabilities	CNY 122.3M
Debt	CNY 21,446
Debt EBITDA	CNY 0
Debt Equity	CNY 0
Debt FCF	CNY 0
Equity	CNY 978.7M
Interest Coverage	4,379.6
Liabilities	CNY 137.3M
Long Term Assets	CNY 739.4M
Long Term Liabilities	CNY 15M
Net Cash	CNY 108.5M
Net Cash By Market Cap	CNY 4.41
Net Cash Growth	-65.82%
Net Debt EBITDA	CNY -1.04
Net Debt Equity	CNY -0.11
Net Debt FCF	CNY -1.63
Tangible Book Value	CNY 960.5M
Tangible Book Value Per Share	CNY 3.21
WACC	6.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.08
Inventory Turnover	3.55
Net Working Capital	CNY 145.7M
Quick ratio	2.48
Working Capital	CNY 254.3M
Working Capital Turnover	CNY 1.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.6%
Dividend Growth	-36.61%
Dividend Growth Years	2%
Dividend per share	CNY 0.09
Dividend Years	9
Dividend Yield	1.05%
Ex Div Date	2025-12-31
Last Dividend	CNY 0.03
Payout Frequency	Semi-Annual
Payout Ratio	33.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.59%
200-day SMA	7.96
3Y total return	-1.89%
50-day SMA	8.09
50-day SMA vs 200-day SMA	50over200
5Y total return	27.51%
All Time High	24.18
All Time High Change	-66.01%
All Time High Date	2016-11-15
All Time Low	4.22
All Time Low Change	94.97%
All Time Low Date	2018-10-12
ATR	0.25
Beta	0.34
Beta1y	0.45
Beta2y	0.58
Ch YTD	8.16
High	8.24
High52	8.62
High52 Date	2026-03-13
High52ch	-4.64%
Low	8.12
Low52	6.78
Low52 Date	2025-06-23
Low52ch	21.24%
Ma50ch	1.64%
Price vs 200-day SMA	3.32%
RSI	56.08
RSI Monthly	57.06
RSI Weekly	53.86
Sharpe ratio	0.9x
Sortino ratio	1.46
Total Return	7.65%
Tr YTD	8.16
Tr1m	3.27%
Tr1w	0.61%
Tr3m	-1.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 58.2M
Operating Income Growth	17.37
Operating Income Growth Q	-10.39
Operating Income Growth3 Y	-1.01
Operating Income Growth5 Y	11.05
Operating margin	13.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	173,646,855%
Net Borrowing	-656,361
Shares Insiders	11.95%
Shares Institutions	2.88%
Shares Out	299,098,170
Shares Qo Q	10.63%
Shares Yo Y	-6.6%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 66.4M
Average Volume	7,291,592.05x
Bv Per Share	3.27
CAPEX	CNY -5.2M
Ch1m	3.27
Ch1w	0.61
Ch1y	18.44
Ch3m	-1.79
Ch3y	-5.41
Ch5y	21.28
Ch6m	0.24
Change	1.23%
Change From Open	0.24
Close	8.12
Days Gap	0.99
Depreciation Amortization	46,385,433
Dollar Volume	55,299,556.8
Earnings Date	2026-08-21
EBIT	CNY 58.2M
EBITDA	CNY 104.5M
EPS	CNY 0.22
F Score	5
FCF	CNY 66.4M
FCF EV Yield	2.82x
FCF Per Share	CNY 0.22
Financing CF	-21,892,305
Fiscal Year End	December
Founded	1,989
Graham Number	4.01798
Graham Upside	-51.12
Income Tax	CNY 8.8M
Investing CF	-64,492,490
Is Primary Listing	1
Last Earnings Date	2026-03-21
Last Report Date	2026-03-31
Last Split Date	2022-04-29
Last Split Type	Forward
Lynch Fair Value	CNY 1.36
Lynch Upside	-83.47
Ma150	7.99
Ma150ch	2.93%
Ma20	7.98
Ma20ch	2.99%
Net CF	-15,164,078
Next Earnings Date	2026-08-21
Open	8.2
P FCF Ratio	37.02
P OCF Ratio	34.33
Payment Date	2025-12-31
Position In Range	83.33
Ppne	278,857,688
Price Date	2026-05-08
Price EBITDA	CNY 23.52
Ptbv Ratio	2.56
Relative Volume	0.94x
Revenue	437,173,421x
Tax By Revenue	2x
Tax Rate	12.13%
Tr6m	0.68%
Volume	6,727,440
Z Score	11.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002817 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.09 annual per share

Payout ratio

+33.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.6%

2 consecutive years of growth

Total shareholder yield

+7.6%

Next ex-dividend date: 2025-12-31

Performance

SHE/002817 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002817?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Share of float held by funds and institutions

Insider ownership

+12.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-6.6%

Negative means the company is buying back shares.

Technical

SHE/002817 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

+3.3%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002817

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002817 stock rating?

she/002817 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002817 analysis?

The full report lives at /stocks/she/002817/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002817?

The latest report frames she/002817 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002817 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.